| Dose level | Dose of drug: anti-PD-1-antibody | Number enrolled | Number evaluable for toxicity |
|---|---|---|---|
| 1a-1 | 1 mg/kg every 2 weeks | 2 | 2 |
| 1a-2 | 3 mg/kg every 2 weeks | 1 | 1 |
| 1a-3 | 200 mg every 3 weeks | 0 | 0 |
| 1a-4 | 10 mg/kg every 2 weeks | 0 | 0 |
| 1b | 200 mg every 3 weeks | 21 | 21 |
| Dose level | Dose of drug: anti-PD-1-antibody | Number enrolled | Number evaluable for toxicity |
|---|---|---|---|
| 1a-1 | 1 mg/kg every 2 weeks | 2 | 2 |
| 1a-2 | 3 mg/kg every 2 weeks | 1 | 1 |
| 1a-3 | 200 mg every 3 weeks | 0 | 0 |
| 1a-4 | 10 mg/kg every 2 weeks | 0 | 0 |
| 1b | 200 mg every 3 weeks | 21 | 21 |